<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The precise biologic mechanisms involved in functional recovery processes in response to <z:hpo ids='HP_0001297'>stroke</z:hpo> such as dopaminergic neurotransmission are still largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>For this purpose, we performed in parallel in vivo magnetic resonance imaging and <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) with [(18)F]fluorodeoxyglucose ([(18)F]FDG) and [(11)C]raclopride at 1, 3, 7, 14, 21, and 28 days after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>In the ischemic territory, PET [(18)F]FDG showed a initial decrease in cerebral metabolism followed by a time-dependent recovery to quasi-<z:mpath ids='MPATH_458'>normal</z:mpath> values at day 14 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The PET with [(11)C]raclopride, a ligand for <z:chebi fb="40" ids="18243">dopamine</z:chebi> D(2) receptor, showed a sustained binding during the first week after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> that declined dramatically from day 14 to day 28 </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, a slight increase in [(11)C]raclopride binding was observed at days 1 to 3 followed by the uppermost binding at day 7 in the contralateral territory </plain></SENT>
<SENT sid="5" pm="."><plain>Likewise, in vitro autoradiography using [(3)H]raclopride confirmed these in vivo results </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, the neurologic test showed major neurologic impairment at day 1 followed by a recovery of the cerebral function at day 28 after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, these results might suggest that <z:chebi fb="40" ids="18243">dopamine</z:chebi> D(2) receptor changes in the contralateral hemisphere could have a key role in functional recovery after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>.Journal of Cerebral Blood Flow &amp; Metabolism advance online publication, 14 November 2012; doi:10.1038/jcbfm.2012.162 </plain></SENT>
</text></document>